CATX insider buying

4 cluster buys

Perspective Therapeutics, Inc. · Healthcare

When two or more insiders at Perspective Therapeutics, Inc. buy CATX on the open market around the same time, that clustered conviction is one of the highest-signal patterns in SEC filing data. Below is every cluster we've detected in CATX plus the full record of qualifying open-market buys, each parsed directly from Form 4 filings and linked back to the source on SEC EDGAR.

Clusters
4
Distinct insiders
7
Total bought
$1.0M
Market cap
$411.7M

Detected clusters

  • Nov 12 – Nov 13, 2025
    Detected Nov 13, 2025
    High conviction2 insiders
    Total bought
    $42.3K
    Market cap
    $411.7M
  • Mar 28 – Mar 31, 2025
    Detected Mar 31, 2025
    High conviction4 insiders
    Total bought
    $316.6K
    Market cap
    $411.7M
  • Nov 25 – Dec 4, 2024
    Detected Dec 4, 2024
    High conviction4 insiders
    Total bought
    $302.4K
    Market cap
    $411.7M

1 more cluster in CATX

Sign in free to see the full history, or go Pro for real-time alerts the moment new insider clusters form.

All notable open-market buys in CATX

Every open-market Form 4 purchase, newest first. Click an insider to see their full buying record across companies.

DateInsiderSharesPriceValueFiling
Nov 13, 2025
Chief Accounting Officer
11,000$2.03$22.3KSEC ↗
Nov 12, 2025
Director
9,498$2.10$19.9KSEC ↗
Mar 31, 2025
Director
38,145$2.14$81.6KSEC ↗
Mar 31, 2025
Director
23,475$2.13$50.0KSEC ↗
Mar 28, 2025
Chief Financial Officer
33,333$2.25$75.0KSEC ↗
Mar 28, 2025
Director
22,192$2.27$50.4KSEC ↗
Mar 28, 2025
Director, Chief Executive Officer
22,026$2.24$49.3KSEC ↗
Mar 28, 2025
Director, Chief Executive Officer
4,650$2.21$10.3KSEC ↗
Dec 4, 2024
Director
25,975$3.85$100.0KSEC ↗
Dec 4, 2024
Director, CEO
8,000$3.77$30.2KSEC ↗
Nov 25, 2024
Director, CEO
14,500$3.78$54.8KSEC ↗
Nov 25, 2024
Chief Financial Officer
10,000$3.88$38.8KSEC ↗
Nov 25, 2024
Director, CEO
6,600$3.80$25.1KSEC ↗
Nov 25, 2024
Director, CEO
5,400$3.80$20.5KSEC ↗
Nov 25, 2024
Director
3,647$3.62$13.2KSEC ↗
Nov 25, 2024
Director
2,619$3.67$9.6KSEC ↗
Nov 25, 2024
Chief Financial Officer
2,400$3.60$8.6KSEC ↗
Nov 25, 2024
Chief Financial Officer
400$3.55$1.4KSEC ↗
Nov 25, 2024
Chief Financial Officer
29$3.94$114.3SEC ↗
Jun 17, 2024
Chief Financial Officer
1,800$9.82$17.7KSEC ↗
Jun 14, 2024
Director
4,504$10.90$49.1KSEC ↗
Jun 14, 2024
Director
83$10.80$896.4SEC ↗
Jun 13, 2024
Director, CEO
100,000$1.17$117.0KSEC ↗
Jun 3, 2024
Director
34,246$1.46$50.0KSEC ↗
May 31, 2024
Director
55,000$1.38$75.9KSEC ↗
4 earlier buys hidden — sign in free to see the full history.

More Healthcare stocks with insider cluster buys

All insider buying in Healthcare

CATX insider buying — FAQ

Are insiders buying CATX stock?
Yes — 7 distinct insiders have bought CATX (Perspective Therapeutics, Inc.) on the open market, including 4 cluster buys where two or more insiders bought within a rolling window. The most recent qualifying activity was Nov 17, 2025.
How much CATX stock have insiders bought?
Insiders have bought a combined $1.0M of CATX across 29 open-market purchases, based on SEC Form 4 filings.
What is an insider cluster buy in CATX?
A cluster buy is two or more distinct Perspective Therapeutics, Inc. insiders — officers, directors, or 10% owners — each buying CATX on the open market within a rolling window. CATX has 4 detected cluster buys to date.
Where does this CATX insider trading data come from?
Every figure is parsed directly from SEC Form 4 filings on EDGAR, and each purchase on this page links back to its original filing document.

How we track insider buying in CATX

We continuously poll SEC EDGAR for new Form 4 filings and parse every open-market purchase (transaction code P). A cluster is recorded when two or more distinct insiders — officers, directors, or 10% owners — each buy CATX within a rolling window. We track clusters at every company size, from micro-caps to mega-caps. Every figure on this page traces back to an official filing; open any row to jump straight to the source document. What counts as a cluster buy?

This page is informational and reflects public filing data. It is not investment advice or a recommendation regarding CATX.